Therefore, widespread use of few ERα + luminal cell lines generate an information bias towards the specific clonal genetic makeup of these cell lines and their other attributes, which may not possibly apply to luminal ERα + breast cancer in general. The gene discussed is ESR1; the disease is breast carcinoma.